Cutler Group LP Catalent, Inc. Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$42.56 - $59.82 $123,424 - $173,478	2,900 Added 725.0%	3,300 $0
Q4 2023 Jan 18, 2024	SELL	$32.18 - $46.57 $328,236 - $475,014	-10,200 Reduced 96.23%	400 $1,000
Q3 2023 Nov 07, 2023	SELL	$44.2 - $50.2 $472,940 - $537,140	-10,700 Reduced 50.23%	10,600 $1,000
Q2 2023 Jul 18, 2023	BUY	$31.86 - $67.26 $318,600 - $672,600	10,000 Added 88.5%	21,300 $16,000
Q1 2023 May 01, 2023	SELL	$45.44 - $74.26 $549,824 - $898,546	-12,100 Reduced 51.71%	11,300 $40,000
Q4 2022 Feb 07, 2023	BUY	$41.39 - $81.0 $968,526 - $1.9 Million	23,400 New	23,400 $3,000
Q2 2022 Aug 04, 2022	SELL	$87.2 - $114.05 $69,760 - $91,240	-800 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$94.19 - $124.49 $28,257 - $37,347	300 Added 60.0%	800 $8,000
Q3 2017 Oct 17, 2017	BUY	$33.75 - $41.67 $16,875 - $20,835	500	500 $1,000

463

148M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.